UNPRECEDENTED ACCESS TO THE BACK OF THE EYE
We are redefining the treatment of retinal diseases. The back of the eye is the location of many irreversible and debilitating ocular conditions, and our proprietary technology precisely administers drug at the site of disease. Our innovative delivery approach revealed that when fluid is injected between the choroid and sclera, the elasticity of the suprachoroidal space (SCS®) allows the drug product to spread spherically toward the posterior regions of the eye where it is absorbed into adjacent, diseased tissue.